Banvit Bandirma Vitaminli Yem Sanayii Anonim Sirketi (IST:BANVT)
Turkey · Delayed Price · Currency is TRY 150.00
-0.30 (-0.20%)
At close: May 26, 2026
IST:BANVT Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 31,343 | 33,492 | 41,275 | 30,789 | 20,274 | 5,321 | |
Revenue Growth (YoY) | 3.01% | -18.86% | 34.06% | 51.86% | 280.98% | 44.69% |
Cost of Revenue | 31,893 | 32,644 | 31,750 | 27,223 | 20,837 | 4,652 |
Gross Profit | -550.39 | 847.97 | 9,525 | 3,566 | -563.25 | 669.88 |
Selling, General & Admin | 3,543 | 3,594 | 4,005 | 2,379 | 1,585 | 373.58 |
Research & Development | 1 | 0.72 | 1.16 | 0.62 | 0.34 | 3.15 |
Other Operating Expenses | 108.2 | 348.44 | -878.84 | -1,135 | -168.86 | -4.73 |
Operating Expenses | 3,653 | 3,943 | 3,127 | 1,245 | 1,417 | 372 |
Operating Income | -4,203 | -3,095 | 6,398 | 2,321 | -1,980 | 297.87 |
Interest Expense | -731.77 | -894.56 | -1,022 | -878.29 | -424.78 | -193.48 |
Interest & Investment Income | 2,086 | 2,092 | 1,339 | 192.84 | 104.25 | 220.44 |
Currency Exchange Gain (Loss) | -269.74 | -269.74 | -409.4 | -2,137 | -576.34 | -167.26 |
Other Non Operating Income (Expenses) | -694.44 | -739.78 | 334.78 | 2,535 | 1,939 | -13.85 |
EBT Excluding Unusual Items | -3,813 | -2,906 | 6,640 | 2,034 | -937.65 | 143.72 |
Gain (Loss) on Sale of Investments | -0.05 | - | - | - | - | -25.78 |
Gain (Loss) on Sale of Assets | - | - | 96.34 | - | - | - |
Pretax Income | -3,813 | -2,906 | 6,736 | 2,034 | -937.65 | 118.29 |
Income Tax Expense | 80.1 | 208.8 | 2,025 | 587.9 | 14.41 | 23.14 |
Earnings From Continuing Operations | -3,893 | -3,115 | 4,711 | 1,446 | -952.06 | 95.15 |
Earnings From Discontinued Operations | - | - | - | -71.26 | -30.61 | - |
Net Income | -3,893 | -3,115 | 4,711 | 1,374 | -982.67 | 95.15 |
Net Income to Common | -3,893 | -3,115 | 4,711 | 1,374 | -982.67 | 95.15 |
Net Income Growth | - | - | 242.75% | - | - | - |
Shares Outstanding (Basic) | - | 100 | 100 | 100 | 100 | 100 |
Shares Outstanding (Diluted) | - | 100 | 100 | 100 | 100 | 100 |
EPS (Basic) | - | -31.14 | 47.10 | 13.74 | -9.82 | 0.95 |
EPS (Diluted) | - | -31.14 | 47.10 | 13.74 | -9.82 | 0.95 |
EPS Growth | - | - | 242.75% | - | - | - |
Free Cash Flow | -24,511 | -23,409 | -16,463 | -15,812 | -14,440 | -3,450 |
Free Cash Flow Per Share | - | -234.04 | -164.60 | -158.09 | -144.37 | -34.49 |
Gross Margin | -1.76% | 2.53% | 23.08% | 11.58% | -2.78% | 12.59% |
Operating Margin | -13.41% | -9.24% | 15.50% | 7.54% | -9.77% | 5.60% |
Profit Margin | -12.42% | -9.30% | 11.41% | 4.46% | -4.85% | 1.79% |
Free Cash Flow Margin | -78.20% | -69.89% | -39.89% | -51.36% | -71.23% | -64.83% |
EBITDA | -2,441 | -1,353 | 8,290 | 4,013 | -1,261 | 525.22 |
EBITDA Margin | -7.79% | -4.04% | 20.08% | 13.03% | -6.22% | 9.87% |
D&A For EBITDA | 1,762 | 1,741 | 1,892 | 1,692 | 719.22 | 227.35 |
EBIT | -4,203 | -3,095 | 6,398 | 2,321 | -1,980 | 297.87 |
EBIT Margin | -13.41% | -9.24% | 15.50% | 7.54% | -9.77% | 5.60% |
Effective Tax Rate | - | - | 30.06% | 28.91% | - | 19.56% |
Advertising Expenses | - | 86.01 | 98.32 | 43.73 | 54.27 | 21.92 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.